HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Coty On Verge Of Unveiling Turnaround Plan; How Will Innovation Enter Into It?

Executive Summary

Following a third quarter marked by continued Consumer Beauty declines and downturns in its Luxury and Professional segments, Coty will present its promised turnaround plan July 1. Company leadership has emphasized a need for portfolio streamlining and targeted advertising and promotional investments; its strategy on the innovation front has been less clear to date.

You may also be interested in...



Coty’s Turnaround Plan Takes Aim At Excess Complexity; $3bn Write-down Reflects P&G Brands’ Erosion

The firm’s “realistic” four-year plan, unveiled 1 July, is designed “to build a better business … while we gradually prepare for growth.” The turnaround effort is expected to cost Coty $600m over the 2020-2023 period and includes a $3bn impairment charge, largely within its ailing Consumer Beauty unit, to be recorded in fiscal 2019.

Coty’s New Leadership Revives Investor Confidence; Now Consumer Biz Must ‘Earn Right To Grow’

Coty’s improved second-quarter results, and Pierre Laubies’ remarks in his first earnings call as the company’s chief exec, charmed the investment community, though a detailed strategy from management – including its plan for the ailing Consumer Beauty unit – is still to come.

Coty Announces New CEO, Board Changes Following Troubled Q1

Coty reported Nov. 7 a Q1 revenue decline of 9.2% due to a constellation of supply-chain issues and continued Consumer Beauty weakness. Less than a week later – and two years after its completion of a $12bn merger with P&G’s beauty business – the firm announces Pierre Laubies as CEO, evidently drawn to his experience integrating combined assets at a Dutch coffee company.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

RS148950

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel